SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
IVERIC bio, Inc. (ISEE) .
本页证实的标准:
- VALUE (20/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($32.75, 18%).
- 分析师共识目标价 $32.75 (-18% 下行风险) — 分析师认为当前价格水平存在明显下行风险。
SharesGrow 综合评分： 26/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
20/100
Price-to-Earnings & upside
Proven by this page
~
健康
67/100
Debt-to-Equity & liquidity
→ Health
估值概览 — ISEE
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-1.45
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$32.75 (-18%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2013 |
$-5.68 |
$0.00 |
$-51.15M |
- |
| 2014 |
$-2.95 |
$41.26M |
$-98.19M |
-238% |
| 2015 |
$-3.06 |
$51.51M |
$-105.72M |
-205.3% |
| 2016 |
$-5.45 |
$50.91M |
$-193.42M |
-379.9% |
| 2017 |
$3.17 |
$209.98M |
$114.21M |
54.4% |
| 2018 |
$1.70 |
$0.00 |
$63.09M |
- |
| 2019 |
$-1.39 |
$0.00 |
$-58.86M |
- |
| 2020 |
$-1.14 |
$0.00 |
$-84.55M |
- |
| 2021 |
$-1.12 |
$0.00 |
$-114.24M |
- |
| 2022 |
$-1.45 |
$0.00 |
$-175.75M |
- |
